Kevin R Sayer, Director, Executive Chair, on July 20, 2026, sold 26,756 shares in Dexcom (DXCM) for $2,041,999. Following the Form 4 filing with the SEC, Sayer has control over a total of 328,970 common shares of the company, with 328,970 shares held directly.
SEC Filing: